Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model

Overview of attention for article published in Intensive Care Medicine Experimental, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

patent: 6 patents

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS

Application EP-4159230-A1

European Patent Office

ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS

Application EP-4159229-A1

European Patent Office

ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS

Application EP-3854414-A1

European Patent Office

INHIBITORS OF ADRENOMEDULLIN FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA BY ERADICATING…

Application WO-2021099600-A1

World Intellectual Property Organisation (WIPO)

ADRENOMEDULLIN BINDER FOR USE IN THERAPY OF CANCER

Grant EP-3082858-B1

European Patent Office

ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OR PREVENTION OF SYMPTOMS OF ILLNESS

Application WO-2019057992-A3

World Intellectual Property Organisation (WIPO)